Hemophilia Care is Entering a New Era
Hemophilia Federation (India) shared a post on LinkedIn:
”Hemophilia care is entering a new era!
The National Hemophilia Awareness Programme 2025 brought together leading voices on 20th September at Radisson Blu, Dwarka, New Delhi, to share the latest innovations and break barriers in hemophilia care. Together, we’re shaping a brighter future!
Dr. Nita Radhakrishnan – Role of Prophylaxis
Prevention is the path to protection!
In her session at the National Hemophilia Awareness Programme 2025, Dr. Nita Radhakrishnan shed light on the role of prophylaxis in hemophilia care. She emphasized how preventive therapy reduces complications, hospital visits, and enables patients to lead healthier lives.
Breaking barriers in hemophilia care is only possible with strong partnerships!
A heartfelt thank you to our partners Novo Nordisk, Roche, Takeda, Grifols, and Pfizer for their unwavering support at the National Hemophilia Awareness Programme 2025. Together, we are moving closer to a future of better care and brighter outcomes.”
Find similar posts on Hemostasis Today.
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’